These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 17181414

  • 21. The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative.
    Nuermberger E, Bishai WR.
    Clin Infect Dis; 2004 Jan 01; 38(1):99-103. PubMed ID: 14679455
    [Abstract] [Full Text] [Related]

  • 22. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents.
    Morrissey I, Colclough A, Northwood J.
    Int J Antimicrob Agents; 2007 Oct 01; 30(4):345-51. PubMed ID: 17643269
    [Abstract] [Full Text] [Related]

  • 23. Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data.
    Zhanel GG, Wolter KD, Calciu C, Hogan P, Low DE, Weiss K, Karlowsky JA.
    J Antimicrob Chemother; 2014 Oct 01; 69(10):2835-40. PubMed ID: 24920652
    [Abstract] [Full Text] [Related]

  • 24. The Sentinel Project: an update on the prevalence of antimicrobial resistance in community-acquired respiratory Streptococcus pneumoniae and Haemophilus spp. in Italy.
    Marchese A, Ardito F, Fadda G, Fontana R, Lo Cascio G, Nicoletti G, Speciale AM, Schito GC.
    Int J Antimicrob Agents; 2005 Jul 01; 26(1):8-12. PubMed ID: 15967638
    [Abstract] [Full Text] [Related]

  • 25. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L.
    Clin Ther; 2006 Dec 01; 28(12):2061-9. PubMed ID: 17296462
    [Abstract] [Full Text] [Related]

  • 26. Macrolide resistance in Streptococci and Haemophilus influenzae.
    Bozdogan B, Appelbaum PC.
    Clin Lab Med; 2004 Jun 01; 24(2):455-75. PubMed ID: 15177849
    [Abstract] [Full Text] [Related]

  • 27. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK, Nichol K, Laing N, Hisanaga T, Nikulin A, Karlowsky JA, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2007 Oct 01; 60(4):733-40. PubMed ID: 17673477
    [Abstract] [Full Text] [Related]

  • 28. Development of macrolide-resistance and comparative activity of telithromycin in streptococci in Austria, 1996-2002.
    Buxbaum A, Forsthuber S, Sauermann R, Gattringer R, Graninger W, Georgopoulos A, Austrian Bacterial Surveillance Network.
    Int J Antimicrob Agents; 2004 Oct 01; 24(4):397-400. PubMed ID: 15380268
    [Abstract] [Full Text] [Related]

  • 29. Clarithromycin in the management of community-acquired pneumonia.
    McCarty JM.
    Clin Ther; 2000 Mar 01; 22(3):281-94; discussion 265. PubMed ID: 10963284
    [Abstract] [Full Text] [Related]

  • 30. [Macrolide antibiotics. Fast development of resistant streptococci].
    Martini B.
    Med Monatsschr Pharm; 2008 Apr 01; 31(4):156. PubMed ID: 18497255
    [No Abstract] [Full Text] [Related]

  • 31. Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections.
    Furuno JP, Metlay JP, Harnett JP, Wilson J, Langenberg P, McGregor JC, Zhu J, Perencevich EN.
    Pharmacoepidemiol Drug Saf; 2006 Jan 01; 15(1):1-9. PubMed ID: 16136615
    [Abstract] [Full Text] [Related]

  • 32. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.
    Bergman M, Huikko S, Huovinen P, Paakkari P, Seppälä H, Finnish Study Group for Antimicrobial Resistance (FiRe Network).
    Antimicrob Agents Chemother; 2006 Nov 01; 50(11):3646-50. PubMed ID: 16940064
    [Abstract] [Full Text] [Related]

  • 33. Microbiologic activity of the newer macrolide antibiotics.
    McCracken GH.
    Pediatr Infect Dis J; 1997 Apr 01; 16(4):432-7. PubMed ID: 9109155
    [Abstract] [Full Text] [Related]

  • 34. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
    Senses Z, Baysallar M, Gür D, Doğanci L.
    Mikrobiyol Bul; 2003 Oct 01; 37(4):225-34. PubMed ID: 14748258
    [Abstract] [Full Text] [Related]

  • 35. The evolution of antimicrobial agents used for the management of CARTIs: a focus on a new class of antimicrobials--the ketolides.
    Sbarbaro JA.
    Am J Manag Care; 2004 Oct 01; 10(12 Suppl):S389-99. PubMed ID: 15603248
    [No Abstract] [Full Text] [Related]

  • 36. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A, Maeda Y, Goldsmith CE, Coulter WA, Mason C, Millar BC, McCalmont M, Rendall J, Elborn JS, Matsuda M, Moore JE.
    J Antimicrob Chemother; 2009 Sep 01; 64(3):501-6. PubMed ID: 19584106
    [Abstract] [Full Text] [Related]

  • 37. Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistance.
    Rapp RP.
    Postgrad Med; 2002 Sep 01; 112(3 Suppl):12-7. PubMed ID: 19667590
    [Abstract] [Full Text] [Related]

  • 38. The macrolides: erythromycin, clarithromycin, and azithromycin.
    Alvarez-Elcoro S, Enzler MJ.
    Mayo Clin Proc; 1999 Jun 01; 74(6):613-34. PubMed ID: 10377939
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of clarithromycin against Streptococcus pneumoniae expressing mef(A)-mediated resistance.
    Maglio D, Capitano B, Banevicius MA, Tessier PR, Nightingale CH, Nicolau DP.
    Int J Antimicrob Agents; 2004 May 01; 23(5):498-501. PubMed ID: 15120730
    [Abstract] [Full Text] [Related]

  • 40. Hidden epidemic of macrolide-resistant pneumococci.
    Klugman KP, Lonks JR.
    Emerg Infect Dis; 2005 Jun 01; 11(6):802-7. PubMed ID: 15963272
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.